HLA-DR6 association confers increased resistance to T. rubrum onychomycosis in Mexican Mestizos

International Journal of Dermatology

Volumn 49, Issue 12, 2010, Pages 1406-1409

  Asz Sigall, Daniel ^a   López García, Lirio ^a   Vega Memije, María Elisa ^a   Lacy Niebla, Rosa María ^a   García Corona, Cristina ^a   Ramírez Rentería, Claudia ^b   Granados, Julio ^c   Villa, Antonio ^c   Ameen, Mahreen ^d   Arenas, Roberto ^a  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HLA DR6 ANTIGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ETHNICITY; FAMILY; FEMALE; FUNGUS CULTURE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNITY; INFECTION RESISTANCE; MALE; MEXICAN MESTIZO; MICROSCOPY; ONYCHOMYCOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; TRICHOPHYTON RUBRUM ONYCHOMYCOSIS;

EID: 78649406724     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04550.x     Document Type: Article

References (30)

1. Pardo-Castello V, Pardo OA. Diseases of the nails. Springfield, IL: Charles C. Thomas, 1960.
2. Vander Straten M, Hossain M, Ghannoum M. Cutaneous infections: Dermatophytosis, onychomycosis and tinea versicolor. Infect Dis Clin N Am, 2003; 17: 87-112.
3. Arenas R. Las onicomicosis. Aspectos clínico-epidemiológicos, micológicos y terapéuticos. Gac Med Méx 1990; 126: 84-91.
4. Sigurgeirsson B, Steingrímsson O. Risk factors associated with onychomycosis. JEADV 2004; 18: 48-51.
5. Tosti A, Hay R, Arenas R. Patients at risk of onychomycosis-risk factor identification and active prevention. JEADV 2005; 19: 13-16.
6. English MP. Trichophyton rubrum infection in families. BMJ 1957; 30: 744-746.
7. Many H, Derbes VJ, Friedman L. Trichophyton rubrum: exposure and infection within household groups. Arch Dermatol 1960; 82: 226-229.
8. Gupta AK, Sibbald RG, Lynde CW, et al. Onychomycosis in children: prevalence and treatment strategies. J Am Acad Dermatol 1997; 36: 395-402.
9. Chang P, Logemann H. Onychomycosis in children. Int J Dermatol 1994; 33: 550-551.
10. Zaias N, Tosti A, Rebell G, et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. Am Acad Dermatol 1996; 34: 302-304.
11. Klein J, Sato A. The HLA system. First of two parts. N Engl J Med 2000; 343: 702-709.
12. Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med 2000; 343: 782-786.
13. Svejgaard E, Jakobsen B, Svejgaard A. HLA studies in chronic dermatophytosis caused by Trichophyton rubrum. Acta Derm Venereol 1983; 63: 254-255.
14. Zaitz C, Campbell I, Moraes J, et al. HLA-associated susceptibility to chronic onychomycosis in Brazilian Ashkenazi Jews. Int J Dermatol 1996; 35: 681-682.
15. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-367.
16. De Leo C, Castelan N, López M, et al. HLA class I and Class II alleles and haplotypes in Mexican mestizos established from serological typing of 50 families. Hum Biol 1997; 69: 809-818.
17. Barquera R, Zúñiga J, Hernández-Díaz R, et al. HLA class I and class II haplotypes in admixed families from several regions of Mexico. Mol Immunol 2008; 45: 1171-1178.
18. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-134.
19. Faergemann J, Correia O, Nowiki R, et al. Genetic predisposition. Understanding underlying mechanisms of onychomycosis. JEADV 2005; 19(Suppl. 1): 17-19.
20. Jones HE. Immune response and host resistance of humans to dermatophyte infection. J Am Acad Dermatol 1993; 28: S12-S18.
21. Browning M, McMichael A. HLA and MHC: genes, molecules and functions. Oxford: BIOS Scientific, 1996.
22. Diaz MF, Pereira AC, Pereira A, et al. The role of HLA antigens in the development of paracoccidioidomycosis. J Eur Acad Dermatol Venerol 2000; 14: 166-171.
23. Louie L, Ng S, Hajjeh R, et al. Influence of host genetics on the severity of coccidiodomycosis. Emerg Infect Dis 1999; 5: 672-680.
24. Van Dam MG, Seaton RA, Hamilton AJ. Analysis of HLA association in the susceptibility to infection with Cryptococcus neoformans var. gatti in papua New guinean population. Med Mycol 1998; 36: 185-188.
25. Taylor ML, Pérez-Mejia A, Yamamoto-Furusho JK, et al. Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the state of Guerrero, Mexico. Mycopatholigia 1997; 138: 137-142.
26. Tsuneto LT, Arce-Gómez B, Petzl-Erler ML, et al. HLA-A29 and genetic susceptibility to chromoblastomycosis. J Med Vet Mycol 1989; 27: 181-5.
27. Beck S, Geraghty D, Inoko H, et al. Complete sequence and gene map of the human major histocompatability complex. Nature 1999; 401: 921-923.
28. Chanussot C, Arenas R. Infección micótica plantar e interdigital en pacientes con onicomicosis. Rev Iberoam Micol 2007; 24: 118-121.
29. Mukherjee P K, Leidich S D, Isham N, et al. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 2003; 47: 82-86.
30. Méndez-Tovar LJ, Manzano-Gayosso P, Velásquez-Hernández V, et al. Resistance to azolic compounds in clinical Trichophyton spp. Strains. Rev Iberoam Micol 2007; 24: 320-322.